{"name":"Autifony Therapeutics Limited","slug":"autifony-therapeutics-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"AUT00063","genericName":"AUT00063","slug":"aut00063","indication":"Other","status":"phase_2"},{"name":"AUT00201","genericName":"AUT00201","slug":"aut00201","indication":"Other","status":"phase_1"},{"name":"AUT00206","genericName":"AUT00206","slug":"aut00206","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"AUT00063","genericName":"AUT00063","slug":"aut00063","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AUT00201","genericName":"AUT00201","slug":"aut00201","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AUT00206","genericName":"AUT00206","slug":"aut00206","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxQSzg1LUhmejlya1UyNHlEWDhzNndOWW9aS3Mwa1ozQmw1RkVEMGxPV056bmJXRUNkRzNGSmI1cTlMQTB0dmgxSElEWTJpYlJ5WGs2RXg5dEhuMzU3LVBUVmQwYVBTS3hPNlF6R2sxLVljeHY5SU9tRWRaME11SGlISjZENkNSMGpMR1hZc1hqaUNpSEpKeUx3VmdIZ1ZmWUtWcmk4TE9hbUpnMWhYQ1VybTMwcDU5LWVmNjZGdTF4dm50eFBHSk85TjEzc3hoVUpwdTlXazdacjlfN21tTmFEMGt2eWJ1YnJvNHVvN1ZB?oc=5","date":"2026-03-30","type":"trial","source":"Barchart.com","summary":"Hearing Loss Clinical Trial Pipeline Shows Potential with Active Contributions from 30+ Key Companies | DelveInsight - Barchart.com","headline":"Hearing Loss Clinical Trial Pipeline Shows Potential with Active Contributions from 30+ Key Companies | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE9vNllnQ19pRmhEZXB2NTVKYVBkemxJaWh3WjVOeWV4MVBRY05Bb1U5cGxJNk9IM3VCU081SE5fcXlCT0RQTktiQ01aVVZjbWh6NGxBbWFzQU5wT3NjeEdRTFFjWGYxUGhWWkZUaURNZjNqSjhPZTZpeA?oc=5","date":"2026-01-02","type":"pipeline","source":"Neurology Today","summary":"Fathers' Use of Valproate Raises Risk of Neurodevelopmental Disorders in Offspring - Neurology Today","headline":"Fathers' Use of Valproate Raises Risk of Neurodevelopmental Disorders in Offspring","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxPdlh6c2tBWmNwTFZDeUZIelN3cllxcGc4Tmx1RTNDV1pzSDNKYWY5TGp0NHNkamc1MDdLWkQ1amlqT3pFN2xWeEQzVnZPV0pTV2J1RFU3eUM1Rm51QUtFbmZrSUNLaWRPM0lPUmZ1SEVsLUpnQ25Mb21VajRtRWRTV0cxeDVzd1JfbDRJd0JhMFN2anN0QkZxLWFZaW52LUFKRnBhTy1NLUo1ZmhnV0VmVnAyZTJKd1h2ajRWcnJwd1g5c0tvM3hBVGVvbGlEcnlldHpJblZhZW5QdVRjSFNURlNuZDdHOTlzaW16NnJGUmVrR2xJNm84TFBtUXVjbnQ2YmdiMXhB?oc=5","date":"2025-02-25","type":"earnings","source":"PR Newswire","summary":"Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2024 Financial Results and Provides 2025 Financial Guidance - PR Newswire","headline":"Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2024 Financial Results and Provides 2025 Financial Guidance","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxONVZKQWhjR3IyUmhXUVgzYmtaeWVsVnUtRXBJLVNqaWs0QVBnUFo4SkgwV25oQUZqa0VlcmVrRUVYUUhKTlFNV2tPRnVKZ3piTDZoVEstRWtKb2lYYV9YSVMyd3FjV216RDhSam5qaVhwdjZ6ajdTYWF5RTBYdDhHckRjYjJhUzR1QURJeDF6M1I3N1BYdVQxZFpqeHZXSS1nQmd4OHdrdVY4M0ZUX040Wg?oc=5","date":"2023-11-15","type":"deal","source":"Insider Media Ltd","summary":"Autifony agrees Jazz Pharmaceuticals deal worth up to $770.5m - Insider Media Ltd","headline":"Autifony agrees Jazz Pharmaceuticals deal worth up to $770.5m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQMHZRbHZPV2dRa3VDcnBJU2FOMG84a19hRm5fQ2MtdzZ5NjVmMEl2LUVnbjgxeTRKV3cwc21wZFg2a3hVTzNBQWgyVUJIekhkbEJQSWJBdklCTFlNTVBnY0VTcXl0Z3JHenQ5ckwxc2xMSTVyOUE0aGZobjVONXg0QldFd21qSkpMQllSekdBMHl1bzZ1NFF4Mmc4RQ?oc=5","date":"2023-11-14","type":"pipeline","source":"The Pharma Letter","summary":"Autifony and Jazz team up in neurological disorders - The Pharma Letter","headline":"Autifony and Jazz team up in neurological disorders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxQZVBLWDNSM1lQWUtIbFBxX3Z0VURQbjBIa0RVXzZWZkxWOWUta2NPZE1MRUdMZXpqM2Z4Qjl4cHJFUUhYWjdTcUJmYUJTeWFWdmxiVl9OcXR6dEpPZXVWWWNmQk5CRC1SVGhfS19nTlI2bl9qWGtGR3JxUlp4aHBtc1lwX0dDdjY2NDc1MnZ6Y0VOVnZSalNZRV8yUjJ5SVVBWVY1NE02OURLLXlKaUxkMkNreVozSjZ0QmdvLTJtOUtfcnhoMDZ0Yg?oc=5","date":"2023-11-08","type":"pipeline","source":"Healio","summary":"XEN1101 significantly reduced monthly seizures for adults with focal-onset epilepsy - Healio","headline":"XEN1101 significantly reduced monthly seizures for adults with focal-onset epilepsy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwJBVV95cUxQa2o2MEhIdWZIWnlaVGFVSTV3ZWZ2NUZvVmFsTUd3ZW9vblNlbVVYNEJDRUYtM0NWMk45T1hqUHd4Q1RYd19aaVA2dnUwREdDSmlwS0ozcEVpMm9wZVUzdFZnd2xQWlJsMjFZMkRyV3N2M0h2bDV2TnFpZmpyVkFlSGthcF9aT2JSVk51YUJMNWcwMVV5dEkxT2NQaHhNeHFBUDVIeTk4TE1idHdzU3BOZU1pbldiLUZUVmhyZHNyOEhzZi1ZV1g5ZHh6ek1LMGtlRk5UWEwwQW9VOGtCQ0xRLUhrRENjYzFVUWZheFNUOXQxQXhaeWxZeFA4a3BUQ3kwaUhB?oc=5","date":"2023-04-05","type":"trial","source":"PR Newswire","summary":"Schizophrenia Clinical Trials Pipeline Analysis: 60+ Companies are Working to Improve the Treatment Space | DelveInsight - PR Newswire","headline":"Schizophrenia Clinical Trials Pipeline Analysis: 60+ Companies are Working to Improve the Treatment Space | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQeTZycFRvSEpDNkxxLXhIamRNdWpZVVMwbEs5T2RFdGJVRzZHSE16VUI4MjVnbmJpenZoM1F3MVRMVzV0QmJGRmtvTGhTOGNxZWU3cUN4YVRhYzc3U2xlc253N19DM2V0N3VXZDVabjM3dDQzZVBHWjd2ZDhreVlYT3FibkRrVzFUdElCTU0tTnowbnlia2c?oc=5","date":"2017-12-19","type":"deal","source":"BioPharma Dive","summary":"Boehringer Ingelheim inks CNS deal with Autifony - BioPharma Dive","headline":"Boehringer Ingelheim inks CNS deal with Autifony","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPMVhRaFFxdUxCblYtRnNTRkVnZVFoQkl4RERBOFRIU196T1hyMWgzVEYwUkFOcTdndl81ZEVBZF9IM1FvczJCTUpDbnozRVlheV9mRmY3RGRPc2paalh1cG5FbmtjX3ZXR09VeUV2dWFhU1ZGb1diM0ZfbjBlNEQyUWNKU2l4RmMwSG9Wb2pXUzhqQQ?oc=5","date":"2015-07-10","type":"pipeline","source":"FinSMEs","summary":"Autifony Therapeutics Raises £8M in Series A Funding - FinSMEs","headline":"Autifony Therapeutics Raises £8M in Series A Funding","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTE1ZNTNIekE4MjF5dko2WF9KTVI1NS1TcDJvejBnWXNUVTdldk5oaGtVTzRfRlpndkt4TzFoUVp0cnlaQ08zWDNXNkNZZTlpbTRLWHBxaTBMZEJrVkt6bzY3VnJFZVVtVWdwODRZVFAtVUQxajA?oc=5","date":"2011-08-22","type":"pipeline","source":"Pharmafile","summary":"GSK invests in UK biotech start-up - Pharmafile","headline":"GSK invests in UK biotech start-up","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_2":1,"phase_1":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}